Intent to Sole Source.pdf
PDF 100 KB Posted
- Solicitation number
- PANHCA-25-P-0000_007708
- Issued by
-
Department of the Army Medical Command
About this file
This document is a Notice of Intent to Sole Source for a hematology analyzer contract. The U.S. Government intends to award a sole source Firm-Fixed Price (FFP) contract to Sysmex Corporation for a hematology analyzer to be used by the Department of Pathology at Bayne-Jones Community Hospital (BJAHC) at Fort Polk, Louisiana. The contract period spans from 01 October 2025 to 30 September 2026, with four additional twelve-month option years. The hematology analyzer is an automated clinical laboratory instrument capable of performing complete blood counts (CBCs) and other hematological tests, including analysis of red and white blood cell counts, platelet count, hemoglobin, hematocrit, and differential white blood cell counts. Interested vendors are requested to respond to this notice on or before 19 June 2025, though the document emphasizes that this is an informational notice and not a competitive proposal request.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| PANHCA-25-P-0000 007708 JA Sole Source FAR Part 13.5_Redacted.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
NOTICE OF INTENT TO SOLE SOURCE
The U.S. Government currently intends to award a supply contract to provide a hematology analyzer on a SOLE SOURCE basis for the Department of Pathology at Bayne-Jones Community Hospital (BJAHC) at Fort Polk, LA. Period of Performance:
Base: 01 October 2025 – 30 September 2026 with four (4) twelve month option years
The proposed contract number will be awarded on a sole source Firm-Fixed Price (FFP) action to:
Sysmex Corporation 577 Aptakisic Rd.
Lincolnshire, IL 60069
Description of Services or Supplies: The product is a hematology analyzer, an automated instrument used in clinical laboratories to perform complete blood counts (CBCs) and other hematological tests. This includes analyzing blood samples to determine parameters such as red blood cell count, white blood cell count, platelet count, hemoglobin, hematocrit, and differential white blood cell counts. The analyzers may also offer additional features like reticulocyte counting, immature granulocyte analysis, and other specialized tests depending on the model.
This sole source requirement is issued under the statutory authority of FAR 13.501- (a)(1)(ii): sole source (including brand name) under the authority of the simplified procedures for certain commercial items
This notice does not constitute a Request for Quote (RFQ)/Invitation for Bid (IFB)/Request for Proposal (RFP) or a promise to issue an RFQ, IFB or RFP in the future. The U.S. Government will not pay for any information or administrative costs incurred in response to this notice.
The notice of intent is not a request for competitive proposals. This sole source synopsis is for informational purposes only.
NOTE: INTERESTED VENDORS, PLEASE RESPOND TO THIS NOTICE ON OR
BEFORE 19 JUNE 2025.
File details come from the government source that posted it. Updated .